Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin Hiroaki SoyamaMorikazu MiyamotoKenichi Furuya Original Paper 22 November 2017 Article: 201
Impact of prior androgen receptor-axis-targeted agents on the clinical activity of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer: comparative assessment between abiraterone acetate and enzalutamide Hideaki MiyakeYuto MatsushitaAtsushi Otsuka Original Paper 21 November 2017 Article: 200
Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients Mi Hyung LeeJeong YeeHye Sun Gwak Original Paper 21 November 2017 Article: 199
MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI Antonella PetrilloRoberta FuscoBiagio Pecori Original Paper 18 November 2017 Article: 198
Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review Agata DylawerskaWojciech BarczakWiktoria Maria Suchorska Review Article Open access 15 November 2017 Article: 197
The role of RNA-binding protein tristetraprolin in cancer and immunity Jian GuoHuiheng QuJiazeng Xia Review Article 09 November 2017 Article: 196
Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer Tsuyoshi MiyaharaNaoko Sueoka-AraganeShinya Kimura Original Paper 09 November 2017 Article: 195
Progranulin and its biological effects in cancer Fabian Arechavaleta-VelascoCarlos Eduardo Perez-JuarezLaura Diaz-Cueto Review Article 07 November 2017 Article: 194
Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA Jasmina I. IvanovaKimberly R. SavernoCharles S. Fuchs Original Paper Open access 04 November 2017 Article: 193
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial I. WalterU. SchulzA. Reichle Original Paper Open access 02 November 2017 Article: 192
Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2 Cristina MeazzaGraziella CefaloRoberto Luksch Original Paper 01 November 2017 Article: 191
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis Teppei MatsumotoShingo HatakeyamaChikara Ohyama Original Paper 31 October 2017 Article: 190
Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond Prasanna SanthanamLilja B. SolnesSteven P. Rowe Review Article 30 October 2017 Article: 189
Primary tumor resection in stage IV unresectable colorectal cancer: what has changed? Michał PędziwiatrMagdalena MizeraAndrzej Budzyński Review Article Open access 30 October 2017 Article: 188
Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy Kyohei HakozakiEiji KikuchiMototsugu Oya Original Paper 23 October 2017 Article: 187